Home › Congenital Heart Defects › NCT05262907

Ventripoint Single Ventricle Study

Assessment of Ventricular Volumes and Function in Single Ventricle Patients Using Ventripoint 3D Echocardiography

Who can join

All ages · All sexes

Inclusion Criteria:

* All patients with functional single ventricles will be included, regardless of age or surgical palliation stage, who have had or are having a clinically ordered transthoracic echocardiogram and/or cardiac MRI.

Exclusion Criteria:

* Patients with congenital heart disease other than functional single ventricles, patients with single ventricle physiology (but not single ventricle anatomy) following a biventricular conversion pathway, or patients unable to understand or consent in English will be excluded.

About the study

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

What is being tested

• Transthoracic Echocardiogram or Cardiac MRI (device)
• Ventripoint Echocardiogram (device)

Sponsor: Duke University · Participants: 100 · Started: Jul 8, 2022

Contact the study team

• Joan Wilson · Phone: 999999999

Official record on ClinicalTrials.gov — NCT05262907

Locations in the U.S.

Conditions

• Congenital Heart Defects
• Univentricular Heart

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.